Siemens Healthineers, NVIDIA Partner to Advance Adaptive Radiotherapy with Agentic AI
The collaboration will explore agentic co-planning, patient-specific simulation, and real-time computing to personalize cancer treatment and expand access to care.
The collaboration will explore agentic co-planning, patient-specific simulation, and real-time computing to personalize cancer treatment and expand access to care.
The FDA has granted premarket notification (510(k)) clearance to the GammaPod from Xcision Medical Systems LLC, Columbia, Md., a new noninvasive stereotactic radiotherapy system intended for use in treating cancer in breast tissue.
The collaboration will explore agentic co-planning, patient-specific simulation, and real-time computing to personalize cancer treatment and expand access to care.